UK trial tests five-day breast cancer radiotherapy
By the AFREEQUE newsroom, based on Punch
Thirty-nine British hospitals are taking part in a clinical trial assessing whether breast cancer radiotherapy can be reduced from three weeks to five days, with an additional targeted dose. More than 1,000 people are enrolled in the FAST-Forward Boost study, funded by the UK National Institute for Health and Care Research; the UK Department of Health says the treatment could eliminate ten hospital visits.
Thirty-nine hospitals in the United Kingdom are taking part in a clinical trial assessing whether radiotherapy for breast cancer can be reduced from three weeks to five days, Punch reports. More than 1,000 people are enrolled in the FAST-Forward Boost study, led by the Institute of Cancer Research in London and funded by the National Institute for Health and Care Research.






